Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "De Cavanagh 2008 Exp Gerontol"

From Bioblast
Β 
(3 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{Publication
{{Publication
|title=de Cavanagh EM, Flores I, Ferder M, Inserra F, Ferder L (2008) Renin-angiotensin system inhibitors protect against age-related changes in rat liver mitochondrial DNA content and gene expression. Exp Gerontol 43: 919-928.
|title=de Cavanagh EM, Flores I, Ferder M, Inserra F, Ferder L (2008) Renin-angiotensin system inhibitors protect against age-related changes in rat liver mitochondrial DNA content and gene expression. Exp Gerontol 43:919-28.
|info=[http://www.ncbi.nlm.nih.gov/pubmed/18765277 PMID: 18765277]
|info=[http://www.ncbi.nlm.nih.gov/pubmed/18765277 PMID: 18765277]
|authors=de Cavanagh EM, Flores I, Ferder M, Inserra F, Ferder L
|authors=de Cavanagh EM, Flores I, Ferder M, Inserra F, Ferder L
Line 6: Line 6:
|journal=Exp Gerontol
|journal=Exp Gerontol
|abstract=Chronic renin-angiotensin system inhibition protects against liver fibrosis, ameliorates age-associated mitochondrial dysfunction and increases rodent lifespan. We hypothesized that life-long angiotensin-II-mediated stimulation of oxidant generation might participate in mitochondrial DNA "common deletion" formation, and the resulting impairment of bioenergetic capacity. Enalapril (10 mg/kg/d) or losartan (30 mg/kg/d) administered during 16.5 months were unable to prevent the age-dependent accumulation of rat liver mitochondrial DNA "common deletion", but attenuated the decrease of mitochondrial DNA content. This evidence - together with the enhancement of NRF-1 and PGC-1 mRNA contents - seems to explain why enalapril and losartan improved mitochondrial functioning and lowered oxidant production, since both the absolute number of mtDNA molecules and increased NRF-1 and PGC-1 transcription are positively related to mitochondrial respiratory capacity, and PGC-1 protects against increases in ROS production and damage. Oxidative stress evoked by abnormal respiratory function contributes to the pathophysiology of mitochondrial disease and human aging. If the present mitochondrial actions of renin-angiotensin system inhibitors are confirmed in humans they may modify the therapeutic significance of that strategy.
|abstract=Chronic renin-angiotensin system inhibition protects against liver fibrosis, ameliorates age-associated mitochondrial dysfunction and increases rodent lifespan. We hypothesized that life-long angiotensin-II-mediated stimulation of oxidant generation might participate in mitochondrial DNA "common deletion" formation, and the resulting impairment of bioenergetic capacity. Enalapril (10 mg/kg/d) or losartan (30 mg/kg/d) administered during 16.5 months were unable to prevent the age-dependent accumulation of rat liver mitochondrial DNA "common deletion", but attenuated the decrease of mitochondrial DNA content. This evidence - together with the enhancement of NRF-1 and PGC-1 mRNA contents - seems to explain why enalapril and losartan improved mitochondrial functioning and lowered oxidant production, since both the absolute number of mtDNA molecules and increased NRF-1 and PGC-1 transcription are positively related to mitochondrial respiratory capacity, and PGC-1 protects against increases in ROS production and damage. Oxidative stress evoked by abnormal respiratory function contributes to the pathophysiology of mitochondrial disease and human aging. If the present mitochondrial actions of renin-angiotensin system inhibitors are confirmed in humans they may modify the therapeutic significance of that strategy.
|keywords=Aging, mitochondria, DNA, reactive oxygen species, gene expression, anti-aging, antioxidant, [[PGC-1alpha]]
|keywords=Aging, Mitochondria, DNA, Reactive oxygen species, Gene expression, Anti-aging, Antioxidant, [[PGC-1alpha]]
|discipline=Mitochondrial Physiology, Biomedicine
|discipline=Mitochondrial Physiology, Biomedicine
}}
}}
{{Labeling
{{Labeling
|area=Respiration, mt-Biogenesis; mt-density, mtDNA; mt-genetics
|area=Respiration, mt-Biogenesis;mt-density, mtDNA;mt-genetics, Genetic knockout;overexpression
|organism=Rat
|organism=Rat
|tissues=Liver
|tissues=Liver
|enzymes=Complex I
|enzymes=Complex I
|injuries=RONS; Oxidative Stress
|injuries=Oxidative stress;RONS
|diseases=Aging; senescence
|diseases=Aging;senescence
|topics=ADP
|couplingstates=OXPHOS
|couplingstates=OXPHOS
|kinetics=ADP; Pi
|instruments=Oxygraph-2k
|instruments=Oxygraph-2k
|discipline=Mitochondrial Physiology, Biomedicine
|discipline=Mitochondrial Physiology, Biomedicine
}}
}}

Latest revision as of 13:49, 20 March 2015

Publications in the MiPMap
de Cavanagh EM, Flores I, Ferder M, Inserra F, Ferder L (2008) Renin-angiotensin system inhibitors protect against age-related changes in rat liver mitochondrial DNA content and gene expression. Exp Gerontol 43:919-28.

Β» PMID: 18765277

de Cavanagh EM, Flores I, Ferder M, Inserra F, Ferder L (2008) Exp Gerontol

Abstract: Chronic renin-angiotensin system inhibition protects against liver fibrosis, ameliorates age-associated mitochondrial dysfunction and increases rodent lifespan. We hypothesized that life-long angiotensin-II-mediated stimulation of oxidant generation might participate in mitochondrial DNA "common deletion" formation, and the resulting impairment of bioenergetic capacity. Enalapril (10 mg/kg/d) or losartan (30 mg/kg/d) administered during 16.5 months were unable to prevent the age-dependent accumulation of rat liver mitochondrial DNA "common deletion", but attenuated the decrease of mitochondrial DNA content. This evidence - together with the enhancement of NRF-1 and PGC-1 mRNA contents - seems to explain why enalapril and losartan improved mitochondrial functioning and lowered oxidant production, since both the absolute number of mtDNA molecules and increased NRF-1 and PGC-1 transcription are positively related to mitochondrial respiratory capacity, and PGC-1 protects against increases in ROS production and damage. Oxidative stress evoked by abnormal respiratory function contributes to the pathophysiology of mitochondrial disease and human aging. If the present mitochondrial actions of renin-angiotensin system inhibitors are confirmed in humans they may modify the therapeutic significance of that strategy. β€’ Keywords: Aging, Mitochondria, DNA, Reactive oxygen species, Gene expression, Anti-aging, Antioxidant, PGC-1alpha


Labels: MiParea: Respiration, mt-Biogenesis;mt-density, mtDNA;mt-genetics, Genetic knockout;overexpression  Pathology: Aging;senescence  Stress:Oxidative stress;RONS  Organism: Rat  Tissue;cell: Liver 

Enzyme: Complex I  Regulation: ADP  Coupling state: OXPHOS 

HRR: Oxygraph-2k